Safety and Tolerability of Secukinumab in Patients with Active Ankylosing Spondylitis: Pooled Safety Analysis of Two Phase 3, Randomized, Controlled Trials

被引：0
|
作者：
Deodhar, Atul A. [1 ]
Baeten, Dominique [2 ]
Sieper, Joachim [3 ]
Porter, Brian [4 ]
Widmer, Albert [5 ]
Richards, Hanno [5 ]
机构：
[1] Oregon Hlth & Sci Univ, Div Arthrit & Rheumat Dis, Portland, OR 97201 USA
[2] Univ Amsterdam, Acad Med Ctr, Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Clin Benjamin Franklin, Berlin, Germany
[4] Novartis Pharmaceut, E Hanover, NJ USA
[5] Novartis Pharma AG, Basel, Switzerland
来源：
ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷
关键词：
SIGNIFICANTLY IMPROVES SIGNS; PLACEBO-CONTROLLED TRIAL; MONOCLONAL-ANTIBODY; INTERLEUKIN-17A; SYMPTOMS; PHASE-3;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2887
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of secukinumab in Asian patients with active ankylosing spondylitis: 52-week pooled results from two phase 3 studies
    Wei, James C. -C.
    Baeten, Dominique
    Sieper, Joachim
    Deodhar, Atul
    Bhosekar, Vaishali
    Martin, Ruvie
    Porter, Brian
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2017, 20 (05) : 589 - 596
  • [2] Safety of secukinumab for the treatment of active ankylosing spondylitis
    Loricera, Javier
    Galindez-Aguirregoikoa, Eva
    Blanco, Ricardo
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (06) : 627 - 634
  • [3] Comparative efficacy and safety of secukinumab and ixekizumab in patients with active ankylosing spondylitis
    Lee, Y. H.
    Song, G. G.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2021, 80 (08): : 776 - 784
  • [4] Secukinumab and Sustained Reduction in Fatigue in Patients With Ankylosing Spondylitis: Long-Term Results of Two Phase III Randomized Controlled Trials
    Kvien, Tore K.
    Conaghan, Philip G.
    Gossec, Laure
    Strand, Vibeke
    Ostergaard, Mikkel
    Poddubnyy, Denis
    Williams, Nicole
    Porter, Brian
    Shete, Abhijit
    Gilloteau, Isabelle
    Deodhar, Atul
    ARTHRITIS CARE & RESEARCH, 2022, 74 (05) : 759 - 767
  • [5] Secukinumab Efficacy on Enthesitis in Patients With Ankylosing Spondylitis: Pooled Analysis of Four Pivotal Phase III Studies
    Schett, Georg
    Baraliakos, Xenofon
    Van den Bosch, Filip
    Deodhar, Atul
    Ostergaard, Mikkel
    Das Gupta, Ayan
    Mpofu, Shephard
    Fox, Todd
    Winseck, Adam
    Porter, Brian
    Shete, Abhijit
    Gensler, Lianne S.
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (08) : 1251 - 1258
  • [6] Clinical efficacy and safety of secukinumab in patients with psoriasis and comorbidities: pooled analysis of 4 phase 3 clinical trials
    Gottlieb, Alice B.
    Wu, Jashin J.
    Griffiths, Christopher E. M.
    Marfo, Kwaku
    Muscianisi, Elisa
    Meng, Xiangyi
    Frueh, Jennifer
    Lebwohl, Mark
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (03) : 1482 - 1490
  • [7] Efficacy and safety of interleukin-17A inhibitors in patients with ankylosing spondylitis: a systematic review and meta-analysis of randomized controlled trials
    Wang, Peng
    Zhang, Shuo
    Hu, Binwu
    Liu, Weijian
    Lv, Xiao
    Chen, Songfeng
    Shao, Zengwu
    CLINICAL RHEUMATOLOGY, 2021, 40 (08) : 3053 - 3065
  • [8] The Comparative Safety of TNF Inhibitors in Ankylosing Spondylitis-a Meta-Analysis Update of 14 Randomized Controlled Trials
    Hou, Li-qiong
    Jiang, Ga-xue
    Chen, Yan-fei
    Yang, Xi-Mei
    Meng, Lei
    Xue, Miao
    Liu, Xiao-guang
    Chen, Xi-chao
    Li, Xiao
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2018, 54 (02) : 234 - 243
  • [9] Effect of Secukinumab on Patient-Reported Outcomes in Patients With Active Ankylosing Spondylitis A Phase III Randomized Trial (MEASURE 1)
    Deodhar, Atul A.
    Dougados, Maxime
    Baeten, Dominique L.
    Wei, James Cheng-Chung
    Geusens, Piet
    Readie, Aimee
    Richards, Hanno B.
    Martin, Ruvie
    Porter, Brian
    ARTHRITIS & RHEUMATOLOGY, 2016, 68 (12) : 2901 - 2910
  • [10] Efficacy and Safety of Intravenous Secukinumab in Patients With Active Axial Spondyloarthritis: Results From a Randomized, Placebo-Controlled, Phase 3 Study
    Deodhar, Atul
    Supronik, Jerzy
    Kivitz, Alan
    Valenzuela, Guillermo
    Kapur, Karen
    Rohrer, Susanne
    Dokoupilova, Eva
    Richards, Hanno B.
    Pavelka, Karel
    ARTHRITIS & RHEUMATOLOGY, 2024,
12345